The role of DQ alpha–beta heterodimers in genetic susceptibility to insulin‐dependent diabetes
1993; Wiley; Volume: 9; Issue: 2 Linguagem: Inglês
10.1002/dmr.5610090202
ISSN1099-0895
Autores Tópico(s)Metabolism, Diabetes, and Cancer
ResumoDiabetes/Metabolism ReviewsVolume 9, Issue 2 p. 71-92 Article The role of DQ alpha–beta heterodimers in genetic susceptibility to insulin-dependent diabetes Dr Ingeborg Deschamps, Corresponding Author Dr Ingeborg Deschamps Department of Paediatric Endocrinology and Diabetes and INSERM U30, Hôpital des Enfants-MaladesService Endocinologie et Diabète de l'Enfant, Hôpital des Enfants-malades, 149 Rue de Sèvres, 75743 Paris Cedex 15, FranceSearch for more papers by this authorIman Khalil, Iman Khalil INSERM U93, Hôpital Saint-Louis, Paris, FranceSearch for more papers by this author Dr Ingeborg Deschamps, Corresponding Author Dr Ingeborg Deschamps Department of Paediatric Endocrinology and Diabetes and INSERM U30, Hôpital des Enfants-MaladesService Endocinologie et Diabète de l'Enfant, Hôpital des Enfants-malades, 149 Rue de Sèvres, 75743 Paris Cedex 15, FranceSearch for more papers by this authorIman Khalil, Iman Khalil INSERM U93, Hôpital Saint-Louis, Paris, FranceSearch for more papers by this author First published: July 1993 https://doi.org/10.1002/dmr.5610090202Citations: 14AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Castano L, and Eisenbarth GS: Type 1 diabetes: a chronic autoimmune disease of human, mouse and rat. Annu Rev Immunol 8: 647–679, 1990. 2 Olmos P, A'Hern R, Heaton DA, Millward BA, Risley D, Pyke DA, and Leslie RDG: The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia 31: 747–750, 1988. 3 Leiter EH, Serreze DV, and Prochazka M: The genetics and epidemiology of diabetes in NOD mice. Immunol Today 11: 147–149, 1990. 4 Baur MP: Genetic Analysis Workshop IV: Insulin-dependent diabetes mellitus. Summary. Genet Epidemiol 6 (Suppl 1): 299–312, 1986. 5 Dupont B, Immunobiology of HLA. Springer-Verlag, New York, 1989. 6 Trowsdale J, Ragoussis J, and Campbell D: Map of the human MHC. Immunol Today 12: 443–445, 1991. 7 Cambon-Thomsen A: HLA population genetics. In Epidemiology and Etiology of Insulin-Dependent Diabetes in the Young, Pediatric Endocrinology. C Levy-Marchal, and P Czernichow, Eds. Karger, Basel, 1992, pp 130–157. 8 Charron DJ, Lotteau V, and Turmel P: Hybrid HLA-DC antigens provide molecular evidence for gene trans-complementation. Nature 312: 157–159, 1984. 9 Lottteau V, Teyton L, Burroughs D, and Charron D: A novel class II molecule (DRα–DQβ) created by mismatched isotype pairing. Nature 329: 339–341, 1987. 10 Dausset J, Legrand L, Lepage V, Contu L, Marcelli-Barge A, Wildloecher I, Benajam A, Meo T, and Degos L: A haplotype study of HLA complex with special reference to the HLA-DR series and to Bf, C2 and glyoxalase I polymorphisms. Tissue Antigens 12: 297–307, 1978. 11 Karr RW, Yu WY, Watts R, Evans KS, and Celis E: The role of polymorphic HLA-DRβ chain residues in presentation of viral antigens to T cells. J Exp Med 172: 273–283, 1990. 12 Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, and Wiley DC: Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364: 33–39, 1993. 13 Hirayama K, Matsushita S, Kikuchi I, Iuchi M, Ohta N, and Sasazuki T: HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans. Nature 327: 426, 1987. 14 Altmann DM, Sansom D, and Marsh SGE: What is the basis for HLA-DQ associations with autoimmune disease? Immunol Today 12: 267–270, 1991. 15 Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasazuk T, Schreuder GMT, Strominger JL, Svejgaard A, and Terasaki PI: Nomenclature for factors of the HLA system, 1991. Tissue Antigens 39: 161–173, 1992. 16 Tsuji K, Aizawa M, and Sasazuki T Eds: HLA 1991. Proceedings of the 11th International Histocompatibility Workshop and Conference. Vol. 2: Disease and Reproduction Studies. Oxford University Press, Oxford, 1992. pp 728. 17 Singal DP, and Blajchman MA: Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue-specific antibodies in patients with diabetes mellitus. Diabetes 22: 429–432, 1973. 18 Nerup J, Platz P, Andersen OO, Christie M, Lyngsoe J, Poulsen JE, Ryder LP, Thomsen M, Staub-Nielsen K, and Svejgarrd A: HL-A antigens in diabetes mellitus. Lancet 2: 864–866, 1974. 19 Dausset J, Hors J, Contu L, Schmid M, Canivet J, Cathelineau G, Lestradet H, and Baron D: Diabète insulinodépendant et HLA. In Journées de Diabétologie de l'Hǒtel-Dieu. Flammarion Médecine-Sciences, Paris, 1977, pp 78–94. 20 Cudworth AG, and Woodrow JC: Evidence for HLA-linked genes in insulin-dependent diabetes mellitus. Br Med J 3: 133–135, 1975. 21 Nerup J, Cathelineau C, Seignalet J, and Thomsen M: HLA and endocrine diseases: diabetes mellitus. In HLA and Disease, J Dausset, and A Svejgaard, Eds. Munksgaard, Copenhagen, 1976, pp 149–159. 22 Barbosa J, Chern MM, Reinsmoen N, Noreen H, Ramsey R, and Greenberg L: HLA-Dw antigens in unrelated juvenile, insulin-dependent diabetics. Tissue Antigens 14: 426–436, 1979. 23 Svejgaard A, Platz P, and Ryder LP: Insulin-dependent diabetes mellitus. Joint report. In Histocompatibility Testing PI Terasaki, Ed. UCLA, Los Angeles, 1980, pp 638–656. 24 Deschamps I, Lestradet H, Bonairi C, Schmid M, Busson M, Benajam A, Marcelli-Barge A, and Hors J: HLA genotype studies in juvenile insulin-dependent diabetes. Diabetologia 19: 189–193, 1980. 25 Platz P, Jacobsen BK, Morling N, Ryder LP, Svejgaard A, Thomsen M, Christy M, Kromann H., Benn J, Nerup J, Green A, and Hauge M: HLA-D and DR antigens in genetic analysis of insulin-dependent diabetes mellitus. Diabetologia 21: 108–115, 1981. 26 Contu L, Deschamps I, Lestradet H, Hors J, Schmid M, Busson M, Benajam A, Marcelli-Barge A, and Dausset J: HLA-haplotype study of 53 juvenile insulin-dependent diabetic families. Tissue Antigens 20: 123–140, 1982. 27 Tiwari JL, and Terasaki PI, HLA and Disease Associations Springer Verlag, New York, 1985. 28 Jenkins D, Mijovic C, Fletcher J, Jacobs KH, Bradwell AR, and Barnett AH: Identification of susceptibility loci for type 1 (insulin-dependent) diabetes by trans-racial gene mapping. Diabetologia 33: 387–395, 1990. 29 Bertrams J, and Baur MP: Insulin-dependent diabetes mellitus. Joint report. In Histocompatibility Testing 1984, ED Albert, MP Baur, and WR Mayr, Eds. Springer-Verlag, Berlin, 1984, pp 348–358. 30 Hawkins BR, Lam KSL, Ma JTC, Low LCK, Cheung PT, Serjeantson SW, and Yeung RTT: Strong association of HLA-DR3/DR9 heterozygosity with early-onset insulin-dependent diabetes mellitus in Chinese. Diabetes 36: 1297–1300, 1987. 31 Bach FH, Rich SS, Barbosa J, and Segall M: Insulin-dependent diabetes-associated HLA-D region encoded determinants. Hum Immunol 12. 59–64, 1985. 32 Carcassi C, Trucco G, Trucco M, and Contu L: A new HLA-DR2 extended haplotype is involved in insulin-dependent diabetes mellitus susceptibility. Hum Immunol 31: 159–164, 1991. 33 Deschamps I, Marcelli-Barge A, Lallemand N, Poirier JC, Bochu V, Prevost P, Busson M, Masset M, Lestradet H, and Hors J: Study of cis and trans interactions between extended HLA-haplotypes in insulin-dependent diabetes. Tissue Antigens 31: 259–269, 1988. 34 Svejgaard A, Jakobsen BK, Platz P, Ryder LP, Nerup J, Christy M, Borch-Johnson K, Parving HH, Deckert T, Molsted-Pedersen L, Kühl C, Buschard K, and Green A: HLA-associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens 28: 237–244, 1986. 35 Clerget-Darpoux F, Babrone MC, Prum B, Lathrop M, Deschamps I, and Hors J: A new method to test genetic models in HLA associated diseases: the MASC method. Ann Hum Genet 52: 247–258, 1988. 36 Owerbach D, Lernmark A, Platz P, Ryder LP, Rask L, Peterson PA, and Ludvigsson J: HLA-D region β-chain endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature 303: 815–817, 1983. 37 Cohen-Haguenauer O, Robbins E, Massart C, Busson M, Deschamps I, Hors J, Lalouel JM, Dausset J, and Cohen D: A systematic study of HLA class II-β DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA (Genetics) 82: 3335–3339, 1985. 38 Tosi R, Vela M, Adorno D, Longo A, Papolo F, Maccarone D, Centis D, Tanigaki N, Raponi MP, Candela A, Campea L, and Ferrara GB: Radioimmunoassay typing gives a more precise definition of the HLA association of type 1 (insulin-dependent) diabetes. Diabetologia 29: 430–433, 1986. 39 Cohen D, Cohen O, Marcadet A, Massart C, Lathrop M, Deschamps I, Hors J, Schuller E, and Dausset J: Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. Proc Natl Acad Sci USA 81: 1774–1778, 1984. 40 Badenhoop K, Schwarz G, Bingley P, Lewis V, Drummond V, Gale EAM, and Bottazzo GF: Restriction fragment length polymorphism analysis of HLA haplotypes in families with type 1 diabetes mellitus. Tissue Antigens 35: 32–39, 1990. 41 Reijonen H, Donen J, Knip M, Michelsen B, and Akerblom HK: HLA-DQ beta chain restriction fragment length polymorphism as a risk marker in type 1 (insulin-dependent) diabetes mellitus: a Finnish family study. Diabetologia 33: 357–362, 1990. 42 Jos J, Farkas D, De Tand MF, Cartron J, Cohen-Haguenauer O, Tozzo E, and Deschamps I: DNA polymorphism analysis of HLA class II genes in unrelated children and in first-degree relatives with type 1 diabetes. Diabetes Res 18: 53–59, 1991. 43 Kohonen-Corish MRJ, Serjeantson S, Lee HK, and Zimmet P: Insulin-dependent diabetes mellitus: HLA-DR and -DQ genotyping in three ethnic groups. Disease Markers 5: 153–164, 1987. 44 Todd JA, Bell JI, and McDevitt HO: HLA DQB gene contributes to susceptibility and resistance in insulin-dependent diabetes mellitus. Nature 329: 599–604, 1987. 45 Horn GT, Bugawan TL, Long CM, Manos M, and Erlich HA: Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals. Hum Immunol 21: 249–263, 1988. 46 Morel PA, Dorman JS, Todd JA, and McDevitt HO: Aspartic acid at position 57 of the HLA-DQβ chain protects against type 1 diabetes: a family study. Proc Natl Acad Sci USA 85: 8111–8115, 1988. 47 Acha-Orbea H, and McDevitt HO: The first external domain of the non-obese diabetic mouse class II I-A β-chain is unique. Proc Natl Acad Sci USA 84: 2435–2439, 1987. 48 Miyazaki T, Uno M, Uehira M, Kikutani H, Kishimoto T, Kimoto M, Nishimoto H, Miyazaki JI, and Yamamura KI: Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice. Nature 345: 722–724, 1990. 49 Slattery RM, Kjer-Nielsen R, and Allison J: Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature 345: 724–726, 1990. 50 Sterkers G, Zeliszewski D, Chaussee AM, Deschamps I, Font MP, Freidel C, Hors J, Betuel H, Dausset J, and Levy JP: HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes. Proc Natl Acad Sci USA (Immunol) 85: 6473–6477, 1988. 51 Lundin KEA, Qvigstad E, Ronningen KS, and Thorsby E: Antigen specific T-cells restricted by HLA-DQw8: importance of residue 57 of the DQβ chain. Hum Immunol 28: 397–405, 1990. 52 Khalil I, D'Auriol L, Gobet M, Morin L, Lepage V, Deschamps I, Park MS, Degos L, Galibert F, and Hors J: A combination of HLA-DQB Asp 57 negative and HLA-DQA Arg 52 confers susceptibility to IDDM. J Clin Invest 85: 1315–1319, 1990. 53 Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, and Capra JD: Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 322: 1836–1841, 1990. 54 Reijonen H, Ilonen J, Knip M, and Akerblom HK: HLA-DQB1 alleles and absence of Asp 57 as susceptibility factors of IDDM in Finland. Diabetes 40: 1640–1644, 1991. 55 Vallet-Colom I, Levy-Marchal C, Zarrouk D, Tichet J, Krishnamoorthy R, Czernichow P, and Elion J: HLA-DBQ1 codon 57 and genetic susceptibility to type 1 (insulin-dependent) diabetes mellitus in French children. Diabetologia 33: 174–176, 1990. 56 Bao MZ, Wang JX, Dorman JS, and Trucco M: HLA-DQβ non-Asp 57 allele and incidence of diabetes in China and in the U.S.A. Lancet 2: 497–498, 1989. 57 Dorman JS, Laporte RE, Stone RA, and Trucco M: Worldwide differences in the incidence of type 1 diabetes are associated with amino-acid variation at position 57 of the HLA-DQβ chain. Proc Natl Acad Sci USA 87: 7370–7374, 1990. 58 Sorrentino R, De Grazia U, Buzzetti R, Nistico L, Iannicola C, Costanzi S, and Tosi R: An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy. Diabetes 41: 904–908, 1992. 59 Khalil I, Spyropoulou M; Mallet C, Loste MN, Douay C, Lepage V, Charron D, and Stavropoulos C: HLA-class II polymorphism and IDDM susceptibility in the Greek population. Eur J Immunogenet 20: 193–199, 1993. 60 Khalil I, Deschamps I, Lepage V, Al-DAccak R, Degos L, and Hors J: Dose effect of cis and trans encoded HLA-DQαβ heterodimers in IDDM susceptibility. Diabetes 41: 378–384, 1992. 61 Ronningen KS, Spurkland A, Iwe T, Vartdal F, and Thorsby E: Distribution of HLA-DQA1 and DQB1 alleles and DQA1–DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens 37: 105–111, 1991. 62 Nepom GT: HLA and type 1 diabetes. Immunol Today 11: 314–315, 1990. 63 Awata T, Kuzuya T, Matsuda A, Iwamoto Y, and Kanazawa Y: Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 35: 419–424, 1992. 64 Aparicio MR, Wakisaka A, Takada A, Matsuura N, and Aizawa M: HLA-DQ system and insulin-dependent diabetes mellitus in Japanese: does it contribute to the development of IDDM as it does in Caucasians? Immunogenetics 28: 240–246, 1988. 65 Yamagata K, Nakajima H, Hanafusa T, Noguchi T, Miyazaki A, Miyagawa J, Sada M, Amemiya H, Tanaka T, Kono N, and Tarui S: Aspartic acid at position 57 of DQβ chain does not protect against type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 32: 762–764, 1989. 66 Lund T, O'Reilly L, Hutchings P, Kanagawa O, Simpson E, Gravely R, Chandler P, Dyson J, Picard JK, Edwards A, Kioussi D, and Cooke A: Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β chain or normal I-E α chain. Nature 345: 727–729, 1990. 67 Lechler RI, Ronchese F, Braunstein NS, and Germain RN: I-A restricted T-cell antigen recognition. J Exp Med 163: 678–683, 1986. 68 Owerbach D, Gunn S, Ty G, Wible L, and Gabbay KH: Oligonucletide probes for HLA-DQA and DQB genes define susceptibility to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 31: 751–757, 1988. 69 Todd JA, Fukui Y, Kitagawa T, and Sasazuki T: The A3 allele of the HLA-DQA1 locus is associated with susceptibility to type 1 diabetes in Japanese. Proc Natl Acad Sci USA 87: 1094–1098, 1990. 70 Vicario JL, Martinez-Laso J, Corell A, Martin-Villa JM, Morales P, Lledo G, Segurado OG, De Juan D, and Arnaiz-Villena A: Comparison between HLA-DRB and DQ DNA sequences and classic serological markers as type 1 (insulin-dependent) diabetes mellitus predictive risk markers in Spanish population. Diabetologia 35: 475–481, 1992. 71 Mijovic CH, Jenkins P, Jakobs KH, Penny MA, Fletcher JA, and Barnett AH: HLA-DQA1 and DQB1 alleles associated with genetic susceptibility to IDDM in a black population. Diabetes 40: 748–753, 1991. 72 Sansom DM, Bidwell JL, Maddison PJ, Campion G, Klouda PT, and Bradley BA: HLA-DQα and DQβ restriction fragment length polymorphisms associated with Felty's syndrome and DR4-positive rheumatoid arthritis. Hum Immunol 19: 269–278, 1987. 73 Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, and Thorsby E: Evidence for a primary association of coeliac disease to a particular HLA-DQ α/β heterodimer. J Exp Med 169: 345–350, 1989. 74 Nepom GT: A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes 39: 1153–1157, 1990. 75 Sheehy MJ: HLA and insulin-dependent diabetes. A protective perspective. Diabetes 41: 123–129, 1992. 76 Guttierrez-Lopez MD, Bertera S, Chantres MT, Vavassori C, Dorman JS, Trucco M, and Serrano-Rios M: Susceptibility to type 1 (insulin-dependent) diabetes mellitus in Spanish patients correlates quantitatively with expression of HLA-DQα Arg 52 and HLA-DQβ non-Asp 57 alleles. Diabetologia 35: 583–588, 1992. 77 Heimberg H, Nagy ZP, Somers G, DeLeeuw I, and Schuit FC: Complementation of HLA-DQA and DQB genes confers susceptibility and protection to insulin-dependent diabetes mellitus. Hum Immunol 33: 10–14, 1992. 78 Giphart MJ, Roep BO, Drabbels J, D'Amaro J, Bruining GJ, Abdulkadir J, and Verduyn W: Relative contribution of HLA-DQA and DQB alleles to predisposition to insulin-dependent diabetes mellitus. Hum Immunol 34: 142–146, 1992. 79 Berressi JP, Djoulah S, Khalil I, Benhamamouch S, Bessaoud K, Touhami M, Hors J, and Deschamps I: HLA-DQA1 and DQB1 study in Algerian type 1 diabetes families. Diabetes Metab 18: 451–458, 1992. 80 Zeliszewski D, Tiercy JM, Boitard C, Gu XF, Loche M, Krishnamoorthy R, Simmonney N, Elion J, Bach JF, Mach B, and Sterkers G: Extensive study of DRB, DQA and DQB gene polymorphism in 23 DR2-positive insulin-dependent diabetes mellitus patients. Hum Immunol 33: 140–147, 1992. 81 Erlich HA, Griffith RL, Bugawan TL, Ziegler R, Alper C, and Eisenbarth G: Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 alleles and unusual DR2 and DR1 haplotypes. Diabetes 40: 478–481, 1991. 82 Clerget-Darpoux F, Babron MC, Deschamps I and Hors J: Complementation and maternal effect in insulin-dependent diabetes. Am J Hum Genet 49: 42–48, 1991. 83 Nepom BS, Schwartz D, Palmer JP, and Nepom GT: Transcomplementation of HLA genes in IDDM. Diabetes 36: 114–117, 1987. 84 Kwok WW, Schwarz D, Nepom B, Thurtle P, Hock R, and Nepom GT: HLA-DQ molecules form α-β heterodimers of mixed allotype. J Immunol 141: 3123–3127, 1988. 85 Gjertsen HA, Lundin KEA, Ronningen KS, Gaudernack G, and Thorsby E: A T-lymphocyte clone recognizing a DQ αβ heterodimer encoded in cis by the DR4–DQw4 haplotype and in trans by DR4–DQw8/DRw8–DQw4 heterozygous cells. Hum Immunol 30: 226–232, 1991. 86 Lotteau V, Sanda J, Teyton L, Turmel P, Charron D, and Strominger J: Modulation of HLA class II antigen expression by transfection of sense and antisense DRα cDNA. J Exp Med 169: 351–356, 1989. 87 Sant AJ, and Germain RN: Intracellular competition for component chains determines class II MHC cell surface phenotype. Cell 57: 797–804, 1989. 88 Charron DJ, Hermans P, Lotteau V, Merlu B, Amesland F, Turmel P, and Teveton L: Interisotypic α- and β-chain assembly as a source of HLA-class II diversity. Immunol Res 9: 234–243, 1990. 89 Djoulah S, Khalil I, Beressi JP, Benhamamouch S, Bessaoud K, Deschamps I, Degos L, and Hors J: HLA-DRB1*0405 haplotype is most strongly associated with IDDM in Algerians. Eur J Immunogenet 19: 381–389, 1992. 90 Forsgren S, Dahl U, Soderstrom A, Holmberg D, and Matsunaga T: The phenotype of lymphoid cells and thymic epithelium correlates with development of autoimmune insulitis in NOD-C57BL/6 allophenic chimeras. Proc Natl Acad Sci USA 88. 9335–9339, 1991. 91 Marsh SGE, and Bodmer JG: HLA class II nucleotide sequences, 1992. Hum Immunol 35: 1–17, 1992. 92 Ju LY, Gu XF, Bardie R, Krishnamoorthy R, and Charron D: A simple nonradioactive method of DNA typing for subsets of HLA-DR4: prevalence data on HLA-DR4 subsets in three diabetic population groups. Hum Immunol 31: 251–258, 1991. 93 Monos DS, Mickelson E, Hansen JA, Baker L, Zmijewski CM, and Kamoun M: Analysis of DR and DQ gene products of the DR4 haplotype in patients with IDDM: possible involvement of more than one locus. Hum Immunol 23: 289–299, 1988. 94 Sheehy MJ, Scharf SJ, Rowe JR, Neme DE, Gimenez MH, Meske LM, Erlich HA, and Nepom BS: A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and - DQ alleles. J Clin Invest 83: 830–835, 1989. 95 Owerbach D, Gunn S, and Gabbay KH: Primary association of HLA-DQw8 with type 1 diabetes in DR4 patients. Diabetes 38: 942–945, 1989. 96 Caillat-Zucman S, Garchon HJ, Timsit J, Assan R, Boitard C, Djilali'Saiah I, Bougneres P, and Bach JF: Age-dependent HLA genetic heterogeneity of type 1, insulin-dependent diabetes mellitus. J Clin Invest 90: 2242–2250, 1992. 97 Morales P, Martinez-Laso J, Martin-Vila JM, Corell A, Vicario JL, Varela P, Perez-Aciego P, and Arnaiz-Villena A: High frequency of the HLA-DRB1*0405 (Dwl5) DQw8 haplotype in Spaniards and its relationship to diabetes susceptibility. Hum Immunol 32: 170–175, 1991. 98 Erlich HA, Bugawan TL, Scharf S, Nepom GT, Tait B, and Griffithy R: HLA-DQβ sequence polymorphism and genetic susceptibility to IDDM. Diabetes 39: 96–103, 1990. 99 Boehm BO, Schifferdecker E, Rosak C, Kuehnl P, Driesel AJ, and Schöffling K: The HLA-DR4 associated DQw8 allele is confined to HLA-DR3/DR4 heterozygous type 1 (insulin-dependent) diabetics. Tissue Antigens 36: 81–82, 1990. 100 Lechler RI: MHC class II molecular structure — permitted pairs: Immunol Today 9: 76–78, 1988. 101 Rotter JI, and Rimoin DL: Diabetes mellitus: the search for genetic markers. Diabetes Care 2: 215–226, 1979. 102 Thomson G, Robinson W, Kuhner MK, Joe SL, MacDonald MJ, Gottschall JL, Barbosa J, Rich SS, Bertrams J, Baur MP, Partanen J, Tait BD, Schober E, Mayr WR, Ludvigsson J, Lindblom B, Farid NR, Thompson C, and Deschamps I: Genetic heterogeneity, modes of inheritance and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet 43: 799–816, 1988. 103 Ludvigsson J, Samuelson U, Beauforts C, Deschamps I, Dorchy H, Francois R, Herz G, New M, Orchard TJ, and Schober E: HLA-DR3 is associated with a more slowly progressive form of type 1 diabetes. Diabetologia 29: 207–210, 1986. 104 Deschamps I, Homberg JC, Janssen F, Lemut H, Vexiau P, and Hors J: Islet-cell antibodies (ICA, CFICA) and HLA genotypes in 107IDD patients and their first degree relatives. Hum Immunol 10: 129–134, 1984. 105 Weinberg CR, Dornan TL, Hansen JA, Raghu PK, and Palmer JP: HLA-related heterogeneity in seasonal patterns of diagnosis in type 1 (insulin-dependent) diabetes. Diabetologia 26: 199–202, 1984. 106 Eberhardt MS, Wagener DK, Orchard TJ, Laporte RE, Cavender DE, Rabin BS, Atchison RW, Kuller LH, Drash AL, and Becker D: HLA-heterogeneity of insulin-dependent diabetes mellitus at diagnosis. The Pittsburgh IDDM study. Diabetes 34: 1247–1252, 1985. 107 Ludvigsson J, Safwenberg J, and Heding LG: HLA-types, C-peptide and insulin-antibodies in juvenile diabetes. Diabetologia 13: 13–17, 1977. 108 Cruickshanks KJ, Vadheim CM, Moss SE, Roth MP, Riley WJ, Maclaren NK, Langfield D, Sparkes RS, Klein R, and Rotter JI: Genetic marker associations with proliferative retinopathy in persons diagnosed with diabetes before 30 yr of age. Diabetes 41: 879–885, 1992. 109 Knip M, Ilonen J, Mustonen A, and Akerblom HK: Evidence of an accelerated B-cell destruction in HLA-Dw3/Dw4 heteroxygous children with type 1 (insulin-dependent) diabetes. Diabetologia 29: 347–351, 1986. 110 Mustonen A, Ilonen J, Tiilikainen A, Kataja M, and Akerblom HK: An analysis of epidemiological data in HLA-typed diabetic children. Diabetologia 1985; 28: 397–400. 111 Karjalainen J, Salmela P, Ilonen J, Surgel HM, and Knip M: A comparison of childhood and adult type 1 diabetes mellitus. N Engl J Med 320: 881–886, 1989. 112 Bertrams J, Baur MP, Gruneklee D, and Gries FA: Age-related association of insulin-dependent diabetes mellitus with BfF1 and the HLA-B18, BfF1 haplotype. Diabetologia 21: 47–49, 1981. 113 Deschamps I, Marcelli-Barge A, Poirier JC, Cohen-Haguenauer O, Abderrahim H, Cohen D, Lestradet H, and Hors J: Two distinct HLA-DR3 haplotypes are associated with age related heterogeneity in type 1 (insulin-dependent) diabetes. Diabetologia 33: 896–901, 1988. 114 Martell M, Marcadet A, Moine A, Boitard C, Deschamps I, Dausset J, Bach JF, and Cohen D: Heterogeneity of HLA genetic factors in IDDM susceptibility. Immunogenetics 31: 233–20, 1990. 115 Cambon-De Mouzon A, Ohayon E, Haptmann G, Sevin A, Abbal M, Sommer E, Vergnes H, and Ducos J: HLA-A, B, C, DR antigens, Bf, C4 and glyoxalase 1 (GLO) polymorphisms in French Basques with insulin-dependent diabetes mellitus. Tissue Antigens 19: 366–379, 1982. 116 Contu L, Carcassi C, and Dausset J: The ‘Sardinian’ HLA-A30, B18, DR3, DQw2 haplotype constantly lacks the 21-OHA and C4B genes. Is it an ancestral haplotype without duplication? Immunogenetics 30: 13–17, 1989. 117 Sheehy MJ, Rowe JR, Fuller TC, Yunis EJ, and Gabbay KH: A minor subset of HLA-DR3 haplotypes is preferentially increased in type 1 (insulin-dependent) diabetes. Diabetologia 28: 891–894, 1985. 118 Gony J, Vexiau P, Lhomme C, Marcelli A, Poirier JC, Bochu V, Cathelineau G, Assan R, Deschamps I, and Hors J: MHC class I, II, III antigen study in 70 insulin-dependent diabetics with associated autoimmune diseases. Tissue Antigens 31: 229–234, 1988. 119 MacDonald M, Gottschall J, Hunter JB, and Winter KL: HLA-DR4 in insulin-dependent parents and their diabetic offspring: a clue to dominant inheritance. Proc Natl Acad Sci USA 83: 7049–7053, 1986. 120 Deschamps I, Hors J, Clerget-Darpoux F, Gardais E, Robert JJ, Marcelli-Barge A, Lestradet H, and Dausset J: Excess of maternal HLA-DR3 antigen in HLA DR3,4 positive type 1 (insulin-dependent) diabetic patients. Diabetologia 33: 425–430, 1990. 121 Rubinstein P, Walker M, Mollen N, Carpenter C, Beckerman S, Suciu-Foca N, McEvoy R, and Ginsberg-Fellner F: No excess of DR3/4 in Ashkenazi Jewish or Hispanic IDDM patients. Diabetes 39: 1138–1143, 1990. 122 Julier C, Hyer RN, Davies J, Merlin F, Soularue P, Brant L, Cathelineau G, Deschamps I, Rotter JL, Froguel P, Boitard C, Bell JI, and Lathrop GM: The insulin-IGF2 region encodes a gene implicated in HLA-DR4 dependent diabetes susceptibility. Nature 354: 155–159, 1991. 123 Rich SS, Weitkamp LR, and Barbosa J: Genetic heterogeneity of insulin-dependent (type 1) diabetes mellitus: evidence from a study of extended haplotypes. Am J Hum Genet 36: 1015–1023, 1984. 124 Dawkins RL, Martin E, Saueracker G, Kay PH, Leaver A, and Christiansen FT: Supratypes and ancestral haplotypes in IDDM: potential importance of central non-HLA MHC genes. J Autoimmun 3 (Suppl 1): 63–68, 1990. 125 Hitman GA, Sachs J, and Cassell P: A DR3-related DXa gene polymorphism strongly associates with insulin-dependent diabetes mellitus. Immunogenetics 23: 47–51, 1986. 126 Tienari PJ, Tuomilehto-Wolf E, Tuomilehto J, Peltonen L, and the DME Study Group: HLA haplotypes in type 1 (insulin-dependent) diabetes mellitus: molecular analysis of the HLA-DQ locus. Diabetologia 35: 254–260, 1992. 127 Easteal S, Kohonen-Corish MRJ, Zimmet P, and Serjeantson SW: HLA-DP variation as additional risk factor in IDDM. Diabetes 39: 855–857, 1990. 128 Faustamn D, Li X, Lin HY, Fu Y, Eisenbarth G, Avruch J, and Guo J: Linkage of faulty major histocompatibility complex class I to autoimmune diabetes. Science 254: 1756–1761, 1991. 129 Caillat-Zucman S, Bertin E, Timsit J, Boitard C, Assan R, and Bach JF: Protection from insulin-dependent diabetes mellitus is linked to a peptide transporter gene. Eur J Immunol 23: 1784–1788, 1993. 130 Thomsen M, Molvig J, Zerbib A, De Preval C, Abbal M, Dugoujon JM, Ohayon E, Svejgaard A, Cambon-Thomsen A, and Nerup J: The susceptibility of to insulin-dependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3,4 heterozygotes. Immunogenetics 28: 320–327, 1988. 131 Marcelli-Barge A, Poirier JC, Chantome R, Deschamps I, Hors J, and Colombani J: Marked shortage of C4B DNA polymorphism among insulin-dependent diabetic patients. Res Immunol 141: 117–128, 1990. 132 Segurado OG, Iglesias-Casarrubios P, Martinez-Laso J, Corell A, Martin-Villa JM, and Arnaiz-Villena A: Autoimmunogenic HLA-DRB1*0301 allele (DR3) may be distinguished at the DRB1 non-coding regions of HLA-B8, DR3, Dw24 and B18, DR3, Dw25 haplotypes. Mol Immunol 28: 189–192, 1991. 133 Badenhoop K, Schwarz G, kTrowsdale J, Lewis V, Usadel KH, Gale EAM, and Bottazzo GF: TNF-α polymorphism in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 32: 445–448, 1989. 134 Pociot F, Molvig J, Wogensen L, Worsaae H, Dalboge H, Baek L, and Nerup J: A tumor necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol 33: 37–48, 1991. 135 Caplen NJ, Patel A, Millward A, Campbell RD, Ratanachaiyavong S, Wong FS, and Demaine AG: Complement C4 and heat-shock protein 70 (HSP 70) genotypes and type 1 diabetes mellitus. Immunogenetics 32: 427–430, 1990. 136 Cavender DE, Wagener DK, Rabin BS, Becker DJ, Orchard TJ, Eberhardt MS, Laporte RE, Drash AL, and Kuller LH: The Pittsburgh IDDM study. HLA antigens and haplotypes as risk factors for the development of IDDM in IDDM patients and their siblings. J Chron Dis 37: 555–568, 1984. 137 Deschamps I, Boitard C, Hors J, Busson M, Marcelli-Barge A, Mogenet A, and Robert JJ: Life-table analysis of the risk of type 1 (insulin-dependent) diabetes in siblings according to islet-cell antibodies and HLA markers. An 8 year prospective study. Diabetologia 35: 951–957, 1992. 138 Bell GI, Horita S, and Karam JH: A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 33: 176–183, 1984. 139 Hitman GA, Tarn AC, Winter RM, Drummond V, Williams LG, Jowett NI, Bottazzo GF, and Galton DJ: Type 1 (insulin-dependent) diabetes and a highly variable locus close to the insulin gene on chromosome 11. Diabetologia 28: 218–222, 1985. 140 Cox NJ, and Spielman RS: The insulin gene and susceptibility to IDDM. Genet Epidemiol 6: 65–69, 1989. 141 Owerbach D, Gunn S, and Gabbay H: Multigenic basis for type 1 diabetes. Association of HRAS1 polymorphism with HLA-DR3, DQw2/DR4, SQw8. Diabetes 39: 1504–1509, 1990. 142 Wong S, Moore S, Orisio S, Millward A, and Demaine AG: Susceptibility to type 1 diabetes in women is associated with the CD3 epsilon locus on chromosome 11. Clin Exp Immunol 83: 69–73, 1991. 143 Abu-Shakra M, and Shoenfeld Y: Gm allotype system and autoimmune disease. Immunol Res 8: 281–291, 1989. 144 Hillert J, and Olerup O: Germ-line polymorphism of TCR genes and disease susceptibility — fact or hypothesis? Immunol Today 13: 47–49, 1992. 145 Möller E, Böhme J, Valugerdi MA, Ridderstad A, and Olerup O: Speculations on mechanisms of HLA associations with autoimmune diseases and the specificity of ‘autoreactive’ T lymphocytes. Immunol Rev 118: 6–19, 1990. 146 Miller JFAP, Morahan G, Slattery R, and Allison J: Transgenic models of T-cell self tolerance and autoimmunity. Immunol Rev 118: 21–35. 147 Sarvetnik N, Liggitt D, Pitts SL, Hansen SE, and Stewart TA: Insulin-dependent diabetes induced in transgenic mice by ectopic expression of class II MHC and interferon γ. Cell 52: 773–782, 1988. 148 Heath WR, Allison J, Hoffmann MW, Schönrich G, Hämmerling G, Arnold B, and Miller JFAP: Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature 359: 547–549, 1992. 149 Ferrick DA, Ohashi PS, Wallace VA, Schilham M, and Mak TW: Transgenic mice as an in vivo model for self-reactivity. Immunol Rev 118: 257–283. 150 Boitard C: The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects. Diabetologia 35: 1101–1112, 1992. 151 Nishimoto H, Kikutani H, Yamamura KI, and Kishimoto T: Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 328: 432–434, 1987. 152 Boitard C, Bendelac A, Richard MF, Carnaud C, and Bach JF: Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies. Transfer of protection by splenic T-cells. Proc Natl Acad Sci USA 85: 9719–9723, 1988. 153 Hanafusa T, Chiovato L, Doniach D, Pujoll-Borell R, Russell RCG, and Bottazzo GF: Aberrant expression of HLA-DR antigen on thyrocytes in Grave's disease: relevance for autoimmunity. Lancet 2: 1111–1115, 1983. 154 Foulis AK and Farquharson MA: Aberrant expression of HLA-DR antigens by insulin-containing β-cells in recent-onset type 1 diabetes mellitus. Diabetes 35: 1215–1224, 1986. 155 In't Veld PA, and Pipeleers DG: In situ analysis of pancreatic islets in rats developing diabetes. Appearance of nonendocrine cells with surface MHC class II antigens and cytoplasmic insulin reactivity. J Clin Invest 82: 1123–1128, 1988. 156 Allison J, Campbell IL, Morahan G, Mandel TE, Harrison LC, and Miller JFAP: Diabetes in transgenic mice resulting from overexpression of class I histocompatibility molecules in pancreatic β cells. Nature 333: 529–533, 1988. 157 Blackman M, Kappler J, and Marrack P: The role of the T-cell receptor in positive and negative selection of developing T-cells. Science 248: 1335–1341, 1990. 158 Sarvetnick N, Shizuru N, Liggitt D, Martin L, McIntyre B, Gregory A, Parslow T, and Stewart T: Loss of pancreatic islet tolerance induced by β-cell expression of interferon γ. Nature 346: 844–847, 1990. 159 Wicker LS, Miller BJ, Coker LZ, McNally SE, Scott S, Mullen Y, and Appel MC: Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J Exp Med 165: 1639–1654, 1987. 160 Todd JA, Airman TJ, Cornall RJ, Ghosh S, Hall JRS, Hearne CM, Knight AM, Love JM, McAleer MA, Prins JB, Rodrigues N, Lathrop M, Pressey A, DeLarato NH, Peterson LB, and Wicker LS: Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature 351: 542–547, 1991. 161 Garchon HJ, Bedossa P, Eloy L, and Bach JF: Identification and mapping to chromosome I of a susceptibility locus for periinsulitis in nonobese diabetic mice. Nature 353: 260–262, 1991. 162 Like AA, Bugerski DL, and Butler L: Diabetic BioBreeding/Worcester (BB/W) rats need to be lymphopenic. J Immunol 136: 3254–3258, 1986. Citing Literature Volume9, Issue2July 1993Pages 71-92 ReferencesRelatedInformation
Referência(s)